Natriuretic Peptide, Brain
"Natriuretic Peptide, Brain" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.
| Descriptor ID |
D020097
|
| MeSH Number(s) |
D06.472.699.584.625 D12.644.548.585.625 D12.776.631.590
|
| Concept/Terms |
Natriuretic Peptide, Brain- Natriuretic Peptide, Brain
- Peptide, Brain Natriuretic
- BNP-32
- BNP 32
- Brain Natriuretic Peptide-32
- Brain Natriuretic Peptide 32
- Natriuretic Peptide-32, Brain
- Peptide-32, Brain Natriuretic
- Natriuretic Factor-32
- Natriuretic Factor 32
- BNP Gene Product
- Type-B Natriuretic Peptide
- Natriuretic Peptide, Type-B
- Type B Natriuretic Peptide
- Natriuretic Peptide Type-B
- Natriuretic Peptide Type B
- Nesiritide
- Brain Natriuretic Peptide
- B-Type Natriuretic Peptide
- Natriuretic Peptide, B-Type
|
Below are MeSH descriptors whose meaning is more general than "Natriuretic Peptide, Brain".
Below are MeSH descriptors whose meaning is more specific than "Natriuretic Peptide, Brain".
This graph shows the total number of publications written about "Natriuretic Peptide, Brain" by people in this website by year, and whether "Natriuretic Peptide, Brain" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 1 | 3 |
| 2008 | 1 | 4 | 5 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 0 | 3 | 3 |
| 2013 | 1 | 4 | 5 |
| 2014 | 2 | 6 | 8 |
| 2015 | 4 | 3 | 7 |
| 2016 | 4 | 2 | 6 |
| 2017 | 3 | 6 | 9 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 5 | 7 |
| 2020 | 4 | 1 | 5 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Natriuretic Peptide, Brain" by people in Profiles.
-
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial. Circ Heart Fail. 2023 03; 16(3):e010111.
-
Biomarker-Based Prediction of Recurrent?Ischemic Events in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2022 11 01; 80(18):1735-1747.
-
Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2022 09 27; 80(13):1205-1216.
-
Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy. Am J Cardiol. 2022 11 15; 183:93-98.
-
Baroreflex activation therapy with the Barostim? device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. Eur J Heart Fail. 2022 09; 24(9):1665-1673.
-
Systemic Inflammation and Cognitive Decrements in Patients With Stage B Heart Failure. Psychosom Med. 2022 Feb-Mar 01; 84(2):133-140.
-
Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. J Heart Lung Transplant. 2022 05; 41(5):619-625.
-
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022 03; 24(3):497-509.
-
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. Clin Res Cardiol. 2021 Aug; 110(8):1334-1349.
-
Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart?Failure. JACC Heart Fail. 2021 06; 9(6):430-438.